Barclays’s Inovio Pharmaceuticals INO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $0 | Sell |
82
-36,327
| -100% | – | ﹤0.01% | 4439 |
|
|
2025
Q1 | $59K | Sell |
36,409
-2,705
| -7% | -$4.38K | ﹤0.01% | 3852 |
|
|
2024
Q4 | $71K | Buy |
39,114
+5,111
| +15% | +$9.28K | ﹤0.01% | 3866 |
|
|
2024
Q3 | $197K | Buy |
34,003
+25,116
| +283% | +$146K | ﹤0.01% | 3490 |
|
|
2024
Q2 | $72K | Buy |
+8,887
| New | +$72K | ﹤0.01% | 3524 |
|
|
2023
Q3 | – | Sell |
-5,393
| Closed | -$29K | – | 4315 |
|
|
2023
Q2 | $29K | Sell |
5,393
-66,172
| -92% | -$356K | ﹤0.01% | 3884 |
|
|
2023
Q1 | $705K | Sell |
71,565
-41,236
| -37% | -$406K | ﹤0.01% | 2383 |
|
|
2022
Q4 | $2.11M | Buy |
112,801
+16,428
| +17% | +$308K | ﹤0.01% | 1615 |
|
|
2022
Q3 | $2M | Buy |
96,373
+95,454
| +10,387% | +$1.98M | ﹤0.01% | 1658 |
|
|
2022
Q2 | $19K | Sell |
919
-2,030
| -69% | -$42K | ﹤0.01% | 4115 |
|
|
2022
Q1 | $126K | Sell |
2,949
-17,965
| -86% | -$768K | ﹤0.01% | 3573 |
|
|
2021
Q4 | $1.25M | Buy |
20,914
+13,806
| +194% | +$826K | ﹤0.01% | 2066 |
|
|
2021
Q3 | $611K | Buy |
7,108
+3,686
| +108% | +$317K | ﹤0.01% | 2508 |
|
|
2021
Q2 | $380K | Sell |
3,422
-9,580
| -74% | -$1.06M | ﹤0.01% | 2612 |
|
|
2021
Q1 | $1.45M | Sell |
13,002
-3,921
| -23% | -$437K | ﹤0.01% | 2093 |
|
|
2020
Q4 | $1.8M | Sell |
16,923
-3,834
| -18% | -$407K | ﹤0.01% | 1627 |
|
|
2020
Q3 | $2.89M | Sell |
20,757
-941
| -4% | -$131K | ﹤0.01% | 1275 |
|
|
2020
Q2 | $7.02M | Buy |
21,698
+5,612
| +35% | +$1.81M | 0.01% | 789 |
|
|
2020
Q1 | $1.44M | Buy |
16,086
+8,354
| +108% | +$746K | ﹤0.01% | 1505 |
|
|
2019
Q4 | $306K | Buy |
7,732
+2,915
| +61% | +$115K | ﹤0.01% | 2965 |
|
|
2019
Q3 | $119K | Sell |
4,817
-637
| -12% | -$15.7K | ﹤0.01% | 3312 |
|
|
2019
Q2 | $192K | Buy |
5,454
+3,407
| +166% | +$120K | ﹤0.01% | 3222 |
|
|
2019
Q1 | $92K | Sell |
2,047
-3,910
| -66% | -$176K | ﹤0.01% | 3373 |
|
|
2018
Q4 | $286K | Sell |
5,957
-468
| -7% | -$22.5K | ﹤0.01% | 2569 |
|
|
2018
Q3 | $429K | Buy |
6,425
+5,527
| +615% | +$369K | ﹤0.01% | 2718 |
|
|
2018
Q2 | $42K | Sell |
898
-1,313
| -59% | -$61.4K | ﹤0.01% | 3341 |
|
|
2018
Q1 | $125K | Sell |
2,211
-4,378
| -66% | -$248K | ﹤0.01% | 3071 |
|
|
2017
Q4 | $326K | Buy |
6,589
+4,837
| +276% | +$239K | ﹤0.01% | 2369 |
|
|
2017
Q3 | $134K | Buy |
1,752
+19
| +1% | +$1.45K | ﹤0.01% | 2576 |
|
|
2017
Q2 | $163K | Buy |
1,733
+1,504
| +657% | +$141K | ﹤0.01% | 2547 |
|
|
2017
Q1 | $18K | Sell |
229
-271
| -54% | -$21.3K | ﹤0.01% | 3393 |
|
|
2016
Q4 | $42K | Sell |
500
-924
| -65% | -$77.6K | ﹤0.01% | 2891 |
|
|
2016
Q3 | $160K | Buy |
1,424
+1,409
| +9,393% | +$158K | ﹤0.01% | 2239 |
|
|
2016
Q2 | $2K | Sell |
15
-412
| -96% | -$54.9K | ﹤0.01% | 3284 |
|
|
2016
Q1 | $41K | Buy |
427
+346
| +427% | +$33.2K | ﹤0.01% | 2602 |
|
|
2015
Q4 | $5K | Sell |
81
-4,854
| -98% | -$300K | ﹤0.01% | 2908 |
|
|
2015
Q3 | $298K | Buy |
4,935
+4,814
| +3,979% | +$291K | ﹤0.01% | 1956 |
|
|
2015
Q2 | $12K | Sell |
121
-203
| -63% | -$20.1K | ﹤0.01% | 3223 |
|
|
2015
Q1 | $31K | Sell |
324
-142
| -30% | -$13.6K | ﹤0.01% | 2949 |
|
|
2014
Q4 | $50K | Sell |
466
-133
| -22% | -$14.3K | ﹤0.01% | 3018 |
|
|
2014
Q3 | $65K | Buy |
599
+481
| +408% | +$52.2K | ﹤0.01% | 2840 |
|
|
2014
Q2 | $14K | Sell |
118
-106
| -47% | -$12.6K | ﹤0.01% | 3525 |
|
|
2014
Q1 | $33K | Sell |
224
-306
| -58% | -$45.1K | ﹤0.01% | 3351 |
|
|
2013
Q4 | $51K | Buy |
+530
| New | +$51K | ﹤0.01% | 3374 |
|